Speaker 01

Prof. Chantal Abergel

CNRS, France Prof. Chantal Abergel is Research Director at CNRS and Director of the Genomics and Structural Information Laboratory. The laboratory is focused on the study of the 4 families of giant viruses currently described, the Mimiviridae and the Pandoraviridae on one hand, and the Pithoviridae and Mollivirus whose first representatives were isolated from permafrost samples more than 30,000 years old. Their discoveries are challenging the concept of virus as well as their origin, their evolution and the role they could have played in the emergence of the cellular life. Chantal Abergel has a Ph.D. in Materials Science.
Read more…

Speaker 05

Dr. D.L. (Bart) Haagmans

Erasmus MC, The Netherlands My research line focusses on the pathogenesis of viral infections and especially those viruses that emerge through zoonotic transmission. This brings together work performed earlier at the Veterinary faculty in Utrecht and more recent work on human viruses in Rotterdam. Over the last five years we have characterised the genome of Middle East respiratory syndrome (MERS) coronavirus, identified the receptor used by this virus and contributed to the identification of the dromedary camel as the reservoir species. We have tested a vaccine candidate that reduces the transmission of MERS-CoV by vaccinating dromedary camels. These studies led to a more detailed understanding of the biology of this emerging virus and led to novel intervention strategies to contain the outbreak. Read more…

Speaker 02

Prof. Zhengli Shi

Wuhan Institute of Virology, China

Prof. Shi is the director of the Center for Emerging Infectious Diseases of the Wuhan Institute of Virology. She got her Ph.D training at Montpellier University II, France, from 1996 to 2000. Her research focuses on viral pathogen discovery through traditional and high-throughput sequencing techniques. She has been studying the wildlife-borne viral pathogens, particularly bat-borne viruses since 2004. Her group has discovered diverse novel viruses/virus antibodies in bats, including SARS-like coronaviruses, adenoviruses, adeno-associated viruses, circoviruses, paramyxoviruses and filoviruses in China. One of her great contributions is to uncover genetically diverse SARS-like coronaviruses in bats with her international collaborators and provide unequivocal evidence that bats are natural reservoirs of SARS-CoV. She has coauthored >130 publications on viral pathogen identification, diagnosis and epidemiology.

Speaker 04

Prof. Vincent Racaniello

Columbia University, USA In 1979 I joined the laboratory of Dr. David Baltimore at Massachusetts Institute of Technology, where I did postdoctoral work on poliovirus. The moratorium on cloning full-length viral genomes had just been lifted, so I proceeded to make a DNA copy of poliovirus RNA, using the enzyme reverse transcriptase. I cloned this DNA into a bacterial plasmid and determined the nucleotide sequence of the poliovirus genome. In an exciting advance, I found that a DNA copy of poliovirus RNA is infectious when introduced into cells. This was the first demonstration of infectivity of a DNA copy of an animal RNA virus, and it permitted previously unthought of genetic manipulations of the viral genome. Today infectious DNA clones are used to study most viruses. Read more…

Speaker 03

Prof. Linda Saif

The Ohio State University, USA Dr. Linda Saif is a Distinguished University Professor at The Ohio State University (OSU) in the Food Animal Health Research Program (OARDC) and the Veterinary Preventive Medicine Department (CVM, OSU). She is a virologist and immunologist, whose research focuses on comparative aspects of enteric and respiratory viral infections (coronaviruses, rotaviruses and caliciviruses) of food animals and humans. Her lab studies mucosal immunity and vaccine development and is currently focusing on the impact of malnutrition and micronutrient deficiencies on vaccines and interactions of probiotics and the gut microbiota with the neonatal immune system, vaccines and viral pathogenesis.
Read more…

Speaker 06

Prof. Stanley Perlman

University of Iowa Health Care, USA Stanley Perlman, a professor of microbiology and immunology and a professor of pediatrics, has studied coronaviruses for 38 years. His laboratory has been interested in the pathogenesis of murine coronavirus infections for several years. Now, they also study three respiratory human coronavirus infections: SARS (Severe Acute Respiratory Syndrome)-coronavirus, Middle East Respiratory syndrome (MERS)-coronavirus, SARS-CoV-2 (COVID-19), human coronavirus-OC43, and human coronavirus-NL63. Read more…

Speaker 06

Dr. Anne Balkema-Buschmann

Deputy Head of Institute / Laboratory Head, Friedrich-Loeffler-Institut, Germany Dr. Balkema-Buschmann is focusing her work on zoonotic viral diseases with a potentially high impact on public health, especially paramyxoviruses. As a trained veterinarian, she is responsible for infection studies with these agents in different species, and she is the head of the BSL4 animal facility and the deputy director of the Institute of Novel and Emerging Infectious Diseases at the Friedrich-Loeffler-Institut (FLI), Federal Research Institute of Animal Health. Read more…

Speaker 06

Robert C. Gallo, MD

Robert C. Gallo, MD, is Co-Founder and Director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine, Baltimore, and Co-Founder and International Scientific Advisor of the Global Virus Network (GVN)

He is recognized internationally for his co-discovery of HIV as the cause of AIDS. As a biomedical research scientist, he since has spent much of his career working to eliminate AIDS and other viral chronic diseases. In the early 1980s, Gallo and his team also pioneered the development of the HIV blood test, which enabled healthcare labors to screen for the AIDS virus for the first time, leading to a more rapid diagnosis while simultaneously protecting patients receiving blood transfusions. His research also helped physicians develop HIV therapies to prolong the lives of those infected with the virus. His 1996 discovery that a natural compound known as chemokines can block the HIV virus and halt the progression of AIDS was hailed by Science magazine as one of that year’s most important scientific breakthroughs.

Speaker 06

Prof. Covadonga Alonso Martí

Professor of Research at CSIC-INIA Dpt. Biotechnology

Covadonga Alonso MD PhD is Professor of research at Consejo Superior de Investigaciones Científicas,Dpt. Biotechnology of INIA, Madrid, Spain. Her group is interested in finding new targets for antivirals against highly pathogenic viruses from a One Health perspective. We focus in finding common targets for SARS-CoV-2, Ebola, and African swine fever virus, based on host-pathogen interactions and innate immunity studies. Our working model has been African swine fever virus (ASFV) in which we have identified cellular molecules that are crucial for viral infection at several levels, including viral entry/uncoating and transport, replication, autophagy, and lipid regulation. This agent causes an acute deadly infection in domestic pigs with a high socio-economic impact in Europe and Asia nowadays. Our goal is to increase knowledge on the mechanisms required for infection in order to find targets for new vaccination and antiviral strategies. I have been Chair of Asfarviridae study group of the ICTV, CEO of the Global African swine fever Research Alliance (GARA) and acting Vicepresident of the Board of the Spanish Society for Virology, between others.

Speaker 06

Prof. Murilo Zerbini

 President of the International Committee on Taxonomy of Viruses (ICTV); Department of Phytopathology at UFV, Brazil

I’m an Agronomist (UFV, Brazil) with a Ph.D. in Plant Pathology (UC Davis, 1996). I started working as an assistant professor at the Department of Plant Pathology at UFV in 1996, becoming a full professor in 2014. My early work was mostly on potyviruses (plant RNA viruses transmitted by aphids), studying virus-host interactions and obtaining transgenic passionfruit plants resistant to woodiness disease. Unfortunately these plants (which were immune to the disease) were never approved for field testing and the work was abandoned in the early 2000’s. Nowadays, my main area of research is the ecology and evolution of begomoviruses (plant ssDNA viruses transmitted by whiteflies). We study viral population in both cultivated and non-cultivated hosts, and are specially interested in the factors that affect spillover from non-cultivated plants to crops. I was editor-in-chief of Tropical Plant Pathology from 2012 to 2017, and associate editor of Archives of Virology, Annals of Applied Biology, Journal of General Virology, Plant Pathology and Virology. I’m currently an Associate Dean of Graduate Studies at UFV. I’ve been involved in virus taxonomy for almost 20 years, initially as a member of both the Potyviridae and Geminiviridae study groups of the International Committee on Virus Taxonomy (ICTV). I was elected to the Executive Committee of the ICTV in 2014, became chair of the Plant Virus subcommittee in 2017, and was elected President of the ICTV in 2020.

Speaker 06

Dr. Andrea Maria Marzi

NIAID Laboratory of Virology, Germany

Dr. Marzi received her Ph.D. in virology from the Friedrich-Alexander University Erlangen-Nurnberg, Germany in 2007 where she studied the glycoprotein-mediated entry of Ebola virus (EBOV) and HIV. Later that year Dr. Marzi moved to Winnipeg, Canada to join Dr. Heinz Feldmann’s group at the National Microbiology Laboratory, Public Health Agency of Canada to work in the BSL4 laboratory on filoviruses and EBOV vaccines.
Read more…

Speaker 06

Prof. Edward Holmes

 ARC Australian Laureate Fellow, Brazil

Professor Eddie Holmes is known for his work on the evolution and emergence of infectious diseases, particularly the mechanisms by which RNA viruses jump species boundaries to emerge in humans and other animals. He currently holds an ARC Australian Laureate Fellowship. He moved to the University of Sydney in 2012. He has studied the emergence and spread of such pathogens as SARS-CoV-2, influenza virus, dengue virus, HIV, hepatitis C virus, myxoma virus, RHDV and Yersinia pestis. His previous appointments include Verne M. Willaman Chair in the Life Sciences at the Pennsylvania State University, USA, and Affiliate Member of the Fogarty International Centre (2005-2012), National Institutes of Health, USA. From 1999-2004 he was Fellow of New College, Oxford. He is also an Honorary Visiting Professor at Fudan University, Shanghai. He is the author of 629 peer-reviewed papers and two books. His publications have >84,000 citations (h-index of 142, i10-index of 561; see http://scholar.google.com.au/citations?user=Syrp1IMAAAAJ&hl=en)

Speaker 06

Prof. Marion Koopmans

Head of the Viroscience Department of Erasmus Medical Center in Rotterdam and collaborator in the COVID-19 Data Portal project, The Netherlands

Professor Marion Koopmans, DVM PhD focuses on global population level impact of rapidly spreading zoonotic virus infections, with special emphasis on foodborne transmission. Her research focuses on unravelling the modes of transmission of viruses among animals and between animals humans, and the use of pathogenic genomic information to unravel these pathways and to signal changes in transmission or disease impact. She is scientific coordinator of COMPARE, a large H2020 funded project (20 MEuro), exploring the potential uses of next generation sequencing techniques for outbreak detection and tracking (www.compare-europe.eu), and co-PI in the FP7 funded PREPARE project (www.prepare-europe.eu) aimed at building a pan-European operational network for rapid and large-scale European clinical research in response to infectious disease outbreaks with epidemic potential. Read more…

Speaker 06

Dr Jerome Kim

Director General of the International Vaccine Institute, South Korea

Jerome H. Kim, MD is the Director General of the International Vaccine Institute (IVI). Dr. Kim led the US Army’s RV144 HIV vaccine trial in Thailand, the first demonstration that an HIV vaccine could prevent human infection and subsequent work identifying immunological and virological correlates. He rose to become the Principal Deputy, US Military HIV Research Program, and Project Manager, HIV Vaccinesm US Army Medical Materiel Development Agency. Read more…

Speaker 06

Dr. Teresa de los Santos

Senior Scientist, Plum Island Animal Disease Center, North East Area, Agricultural Research Service, U.S. Department of Agriculture

Teresa de los Santos is a senior scientist at the Foreign Animal Disease Research Unit at Plum Island Animal Disease Center in Orient, NY. She holds a BS in Biochemistry from the University of Buenos Aires, Argentina, a MA in Microbiology from Columbia University, NY. and a PhD in Biological Chemistry from the University of Buenos Aires, Argentina and Stony Brook University, NY, USA.

Since 2003, Teresa has been working at the Foreign Animal Disease Research Unit (FADRU), Plum Island Animal Disease Center, of the Agricultural Research Service at the US Department of Agriculture. 
Read more…

Speaker 06

Prof. Jean Rommelaere

Honorary Professor, Clinical Cooperation Unit “Virotherapy”, DKFZ, Germany

Jean Rommelaere is former Head of the Tumor Virology Division at the German Cancer Research
Center (DKFZ), and former Director of two Research Units at the French National Institute of Health
and Medical Research (INSERM) in Heidelberg, Germany. His professional career comprises steps
in Belgium (PhD holder, qualified researcher and lecturer at the Free University of Brussels-ULB),
USA (post-doctoral fellow at the Massachusetts Institute of Technology, Cambridge, and Yale
University School of Medicine, New Haven), France (INSERM Research Director at the Pasteur
Institute, Lille), and Germany (professor at the University of Heidelberg). As a result of his initial
activities in the field of DNA replication and repair, he became interested in using viruses to probe
these processes and their deregulation in malignantly transformed cells. Over the past 25 years, his
research has focused more particularly on the interactions between parvoviruses and transformed
cells, and on the development of oncolytic parvoviruses as potential cancer therapeutics. He has
published more than 250 scientific papers and reviews in peer-reviewed journals and books.

Speaker 06

Prof. Mylène Ogliastro

INRA Research Director, University of Montpellier, France

My main interests are insects and viruses, looking at their interactions at different levels, from molecules to communities. One of my particular focus is to develop new virus-based strategies  to specifically control insects. This application of virology requires a deep understanding of basic virology issues, ie what determines host range and specificity and how these interactions evolve. The models we work with in the lab are caterpillars  (Spodoptera sp) and small single stranded naked DNA viruses  (densoviruses). 

As a main issue for orally transmitted viruses is to cross the gut of their host. Viruses are wonderfull vehicules to explore “The Inside Story of body’s Most Underrated Organ”. The gut is beautifull!

Speaker 06

Prof. Klaus Hedman

Professor in Clinical Virology, University of Helsinki, Finland

Klaus Hedman, MD, Professor of Clinical Virology and Chief Physician, has elucidated the pathogenesis of infectious diseases and invented methods for their diagnosis. His team introduced the measurement of IgG-avidity into virus and parasite diagnostics. They currently work on (i) newly discovered human DNA viruses, (ii) a revolutionary FRET-based homogenous (wash-free, single-step) point-of-care serodiagnostic concept, and (iii) the occurrence of viral nucleic acids in ancient human tissue remains (archeovirology).

Speaker 06

Prof. Marietjie Venter

Department Medical Virology, University of Pretoria, South Africa

Marietjie Venter obtained her PhD(Medical Virology) through Wits (2003) on Respiratory Syncytial Virus and received postdoctoral training at the National Institute for Allergy and Infectious Diseases, USA(2003) on West Nile virus. She worked on respiratory- and zoonotic arboviruses since 1999, as medical scientist at the National Institute for Communicable diseases, (NICD) National Health laboratory Services (NHLS) and University of Pretoria. From 2009-2014 she was co-director, Centre for Respiratory diseases and Meningitis, NICD and Director, National Influenza Centre at the NICD. From 2014-2016 she worked for the US-Centers of Disease Control and Prevention (US-CDC), Global Disease Detection Centre, South Africa as One Health Program director. Read more…

Speaker 06

Prof. Hanu Pappu

Department of Plant Pathology. Washington State University, USA

Hanu Pappu was born in India. He obtained his B.S. degree in agriculture from the Agricultural College, Bapatla, in 1982 and an M.S. degree in plant pathology with Anupam Varma from the Indian Agricultural Research Institute, New Delhi, in 1985. He earned his Ph.D. degree in plant science with Chuji Hiruki from the University of Alberta, Edmonton, in 1990. After his post-doctoral work with Charles Niblett at the University of Florida, he joined the University of Georgia as an assistant professor and was promoted to associate professor. In 2002, Pappu joined Washington State University (WSU), Pullman, as an associate professor and was promoted to full professor in 2010. He holds the Samuel H. Smith Distinguished Professorship at WSU. Pappu served as department chair for 5 years, from 2008 to 2013. Pappu leads a highly productive and internationally recognized research program in genomics and biotechnology of RNA and DNA viruses that are economic constraints to the production of several horticultural and field crops. He has published more than 172 refereed journal articles, including 100 in the last 10 years, and 14 invited review articles. He has given 34 invited presentations at national and international conferences and obtained more than $5 million in competitive extramural grants in the last 5 years. Read more…

Speaker 06

Prof. Khatijah Yusoff

Professor in Microbiology, Universiti Putra Malaysia, Malaysia

Khatijah Yusoff obtained a BSc in Microbiology in 1979 and PhD in 1983 from La Trobe University,
Australia. She joined Universiti Putra Malaysia as a lecturer and became a full Professor in 2001.
Since then, she has held various administrative posts including the Dean of Faculty of Biotechnology
and Biomolecular Sciences and the Deputy Vice-Chancellor (Academic & International Affairs). From
2008-2010, she was seconded to the Ministry of Science, Technology and Innovation Malaysia as the
Deputy Secretary-General (Science). She is a Council member of the Academy of Sciences Malaysia
(ASM), Vice-President of the Islamic World Academy of Sciences (IAS) and Vice-President of The
World Academy of Sciences (TWAS).Read more…

Speaker 06

Prof. Heikki Hyöty

Professor of Virology, Tampere University, Finland

Heikki Hyöty is working as the full-time professor of virology at the Tampere University, Finland. He has graduated in medicine, made his PhD in virology, and his principal research interest is the role of microbes in immune-mediated diseases, particularly type 1 diabetes. He has studied interactions between viruses and immune system and their contribution to the development of human type 1 diabetes. His scientific contributions include the first prospective studies evaluating viral etiology of type 1 diabetes and leading to the identification of the association between enterovirus infections and initiation of the beta-cell damaging process. He has contributed to the development of other innovative research strategies, e.g. the collection of pancreas tissues from cadaveric organ donors with type 1 diabetes and studies in unique ecological settings in populations that share the same ancestry but live in contrasting environments (Karelian Republic of Russia and Finland). Read more…

Speaker 06

Prof. Kanta Subbarao

Director of the WHO Collaborating Centre for Reference and Research on Influenza, University of Melbourne, Australia

Professor Kanta Subbarao was appointed Director of the WHO Collaborating Centre for Reference and Research on Influenza in 2016. Prior to her arrival in Melbourne, she was Chief of the Emerging Respiratory Viruses Section of the Laboratory of Infectious Diseases, NIAID, National Institutes of Health (NIH) in the United States from 2002-2016 and chief of the Molecular Genetics Section of the Influenza Branch at the US CDC from 1997-2002.
Read more…

Speaker 06

Prof. Evgeny Nikolaev

Professor, Center for Computational and Data-Intensive Science and Engineering, Center for Translational Biomedicine, Skoltech, Russia

Prior to Skoltech, Evgeny was a professor of chemical physics and led the Laboratory of Ion and Molecular Physics at the Institute of Energy Problems of Chemical Physics of the Russian Academy of Sciences.

At the same time, he worked as the head of the Laboratory for Mass Spectrometry of Biomacromolecules at the Institute of Biochemical Physics of the Russian Academy of Sciences. Outside of that position, Evgeny was the lead scientific member of the Orehovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences. Previously he has researched at the Institute of Chemical Physics of the Russian Academy of Sciences.
Read more…

Speaker 06

Prof. Neena Mitter

Centre Director, Centre for Horticultural Science, University of Queensland, Australia

Prof Neena Mitter, Director, Centre for Horticultural Science, Queensland Alliance for Agriculture and Food Innovation, the University of Queensland has been involved in molecular biology and biotechnology in Australia and India for over 20 years. Her scientific journey began as an agricultural scientist in India, where she learned first-hand the significance of agriculture in shaping the world, economically, socially, environmentally and politically. Her innovations creating change by research at UQ, namely ‘BioClay for crop protection’, ‘Nanovaccines for animal health’, and “Clonal propagation of avocado using plant stem cells” are ground breaking platform technologies impacting agricultural production, environmental sustainability and socio-economic dynamics of farming community. She is at the forefront of increasing UQ’s international presence, to support global collaborations in priority geographies, particularly India. With increased scrutiny on use of chemicals as crop and animal disease control agents; she is focused on developing clean technologies for the horticulture of tomorrow.
Read more…

Speaker 06

Prof James Van Etten

William Allington Distinguished Professor of Plant Pathology, University of Nebraska-Lincoln, USA

Research in the Van Etten laboratory focuses on the isolation and characterization of large icosahedral, dsDNA-containing, plaque-forming viruses that infect certain unicellular, eukaryotic chlorella-like green algae. These viruses are ubiquitous in fresh water from all over the world. The chlorella viruses have genomes as large as 370 kb that contain as many as 400 protein encoding- and 16 tRNA encoding-genes. Besides their large genomes, the chlorella viruses have other unexpected features: (i) They encode multiple DNA methyltransferases and DNA restriction endonucleases. (ii) Unlike other glycoprotein-containing viruses, chlorella viruses encode most, if not all, of the components required to glycosylate their proteins. (iii) Many chlorella virus-encoded proteins are either the smallest or among the smallest proteins of their class. Consequently, these proteins serve as models for mechanistic and structural studies. Infection by the chlorella viruses resembles bacterial infection by tailed bacteriophages in many respects.

Speaker 06

Dr Kristiina Mäkinen

University Lecturer, Department of Microbiology, University of Helsinki, Finland

The research work in Dr Kristiina Mäkinen’s laboratory at the University of Helsinki, Finland, focuses on molecular elucidation of the different stages of potyvirus infection and investigates localization and coordination of viral processes within the infected plant cells. This work has revealed various cellular pathways functioning during infection and led to identification of infection-associated molecular complexes essential for potyviral replication, translation, RNA silencing suppression and virion encapsidation. Dr. Mäkinen has presented these research findings in many international congresses as an invited speaker and published over 70 research articles, reviews and book chapters in respected international journals. Read more…

Speaker 06

Prof. Øystein Evensen

Professor, Department of Paraclinical Sciences, Norwegian University of Life Sciences, Norway

Øystein Evensen is head of the research group “Host-pathogen interactions in infection and immunity” at the Faculty of Veterinary Medicine. He got his degree in veterinary medicine from the Norwegian School of Veterinary Science in 1984 and his PhD in pathology from the same institution in 1987.

He worked for more than 10 years after his PhD as post-doc and research scientist at the Norwegian Veterinary Institute in Oslo, Norway, more than 7 years in pharmaceutical industry (1995-2002) with development of vaccines for finfish, particularly salmon. Over the last 18 years he has been full professor at the Norwegian University of Life Sciences, Faculty of Veterinary Medicine, where he heads a research group of more than 15 people, that includes 2 associate professors, research scientists, post docs and PhD students. 
Read more…

Speaker 06

Dr Karyn Johnson

Associate Professor, School of Biological Sciences, University of Queensland, Australia

Invertebrate Virology
Insects are commonly infected with viruses. We study the interactions between viruses and their insect or arthropod hosts. Viruses are obligate parasites, that is, they are completely dependent on the host cell machinery to complete their replication cycle. During infection, viruses commonly cause pathology in the host. For these reasons, viruses and hosts are in a constant evolutionary arms race. The host evolves antiviral mechanisms to prevent virus infection, while the virus adapts to overcome these host responses. Insects are ideal hosts to understand both the host response and the virus mechanisms for controlling the host.
Read more…

Speaker 06

Prof. Cameron Myhrvold

Assistant Professor of Molecular Biology at Princeton University, USA

Cameron Myhrvold is an Assistant Professor of Molecular Biology at Princeton University. His work specializes in the development of CRISPR-based technologies for studying RNA, with an emphasis on detecting and destroying RNA viruses. He received a PhD in Systems Biology from Harvard in 2016. His PhD studies in synthetic biology and nucleic acid nanotechnology, supported by a Fannie and John Hertz Foundation fellowship, involved the development of three technologies that demonstrated a variety of applications for self-assembled nanostructures. During his postdoc, he turned his attention towards the RNA-targeting CRISPR effector protein Cas13, where he has led or co-led the development of four Cas13-based technologies, including CARMEN, CARVER, and SHINE.

Speaker 06

Prof. Mzia Kutateladze

Director, G. Eliava Institute of Bacteriophages, Microbiology and Virology, Georgia

Dr. Mzia Kutateladze represents the world-renown G. Eliava Institute of Bacteriophages, Microbiology and Virology, headquartered in Tbilisi, Georgia. Currently, she is the Director of Eliava Institute, as well as the President of the Eliava Foundation, a collection of commercial spin-offs. She oversees, coordinates and manages the research directions and programs of the Institute. She is the author or co-author of more than 80 scientific papers. Her scientific background is in microbiology and molecular biology, bacteriophage research and application. Dr. Kutateladze was a manager and a leading scientist of number of scientific research projects. She is serving as a project and papers reviewer for national and international funding agencies and scientific journals.

Speaker 06

Prof. Curtis Suttle

FRSC, Professor, Distinguished University Scholar, University of British Columbia, Canada

Curtis Suttle’s research focuses on viruses and their diversity, evolution, and function in the global system, with an emphasis on the oceans. As a frequently invited speaker at Universities and International symposia, as well as a commentator in print, video and television, he makes a persuasive case that viruses encompass much of the genetic diversity on Earth and are major drivers of global biogeochemical cycles. His work has helped shift the paradigm from viruses being enemies and agents of death, to the perspective that viruses are essential to life on Earth. His scholarship has been recognized by being appointed as a Fellow of the Royal Society of Canada and American Academy of Microbiology, as well as appointments with the Canadian Institute for Advanced Research, the Peter Wall Institute for Advanced Research, and the Institute for Advanced Studies at the Hong Kong University of Science and Technology. As well as being a Distinguished University Scholar and Wall Scholar at the University of British Columbia, he is a recipient of the A.G. Huntsman, Timothy R. Parsons and G. Evelyn Hutchinson Medals in Marine Science.

Speaker 06

Prof. Stephanie Karst

Associate Professor, Emerging Pathogens Institute, University of Florida, USA

Noroviruses are responsible for significant human disease, causing over 90% of nonbacterial epidemic gastroenteritis worldwide. It is also a major cause of severe diarrhea in children in developing nations and has been estimated to cause 200,000 deaths in this population each year. Primary human norovirus infection does not elicit lasting protective immunity, a fact that could greatly affect the efficacy of vaccination strategies. Our long term goal is to elucidate the mechanisms by which noroviruses avoid the induction of protective immunity, ultimately translating this knowledge into successful vaccination approaches. Little is known regarding the pathogenesis of human noroviruses or the immune responses that control them because there has previously been no small animal model of norovirus infection. Read more…

Speaker 06

Dr. Egbert Mundt

Head of Global Poultry Vaccine R&D, Boehringer Ingelheim, Germany

Dr. Egbert Mundt graduated as DVM from the Veterinary College of the Humboldt University Berlin, in 1989. He started his work in poultry virology at the Friedrich Loeffler Institute, Insel Riems, Germany at the same year. In 1992, he became staff scientist and later group leader at the Federal Research Institute for Animal Health, Insel Riems, Germany, until 2006. He obtained his PhD in molecular virology at the Veterinary College of the University Giessen in 1995. Dr Mundt was visiting scientist at the Veterinary College of the University of Maryland in 1995. Next, in 2000 he obtained the title Specialist in Veterinary Virology. Read more…

Speaker 06

Prof. Christina Wege

Head of Research Unit Molecular & Synthetic Plant Virology, University of Stuttgart, Germany

Prof. Dr. Christina Wege has been at the University of Stuttgart since 1994 and is specifically interested in plant viruses. The Research Unit Molecular and Synthetic Plant Virology focuses on plant viral building blocks for smart materials and bionanotechnoloy in various areas of research, on molecular interactions between plants and viruses in single and mixed infections and on phytoviral engineering.

Speaker 06

Dr. Fabien Zoulim

Professor of Medicine, Lyon University, Institut Universitaire de France; Medical Director, Hepatology Department at the Hospices Civils de Lyon; Scientific Director, Viral Hepatitis Research Laboratory, INSERM U1052, Cancer Research Center of Lyon, France

Fabien Zoulim obtained his M.D. in Gastroenterology and Hepatology in Lyon Medical School in 1991. He has also obtained a PhD in Molecular and Cellular Biology and was trained as a post-doctoral researcher at Fox Chase Cancer Center in Philadelphia. He is Professor of Medicine at Lyon I University since 1997. He is currently Medical Director of the Hepatology Department at the Hospices Civils de Lyon, and Scientific Director of the Department of Immunology and Virology of INSERM Unit 1052 where he is leading the team on ‘Antiviral therapy of viral hepatitis’. Dr Zoulim has served as an Associate Editor for Journal of Hepatology and is currently Associate Editor for Gut. Read more…

Speaker 06

Prof. Kari Nadeau

Naddisy Foundation Professor of Pediatric Food Allergy, Immunology and Asthma, Professor of Pediatrics, Senior Fellow at the Woods Institute and Professor, by courtesy, of Otolaryngology and of Epidemiology and Population Health at LPCH

Dr. Kari Nadeau is the Naddisy Foundation Endowed Professor of Medicine and Pediatrics and, Director of the Sean N. Parker Center for Allergy and Asthma Research at Stanford University. She is Section Chief in Asthma and Allergy in the Pulmonary, Allergy and Critical Care Division at Stanford. She is the Sr. Director of Clinical Research for the Division of Hospital Medicine.
Read more…

Speaker 06

Prof. Neil Ferguson

Vice-Dean (Academic Development), Faculty of Medicine, Imperial College London

My research aims to improve understanding of the epidemiological factors and population processes shaping infectious disease spread in human and animal populations. A key practical focus is the analysis and optimisation of intervention strategies aimed at reducing transmission or disease burden. Much of my work is applied, informing disease control policy-making by public and global health institutions.
Read more…

Speaker 06

Dr. Emilia Liana Falcone

Director, IRCM Post-COVID-19 research clinic; Director, Microbiome and Mucosal Defense Research Unit at the Montreal Clinical Research Institute (IRCM), Canada

Dr. Emilia Liana Falcone is the Director of the IRCM Post-COVID-19 research clinic and the
Director of the Microbiome and Mucosal Defense Research Unit at the Montreal Clinical
Research Institute (IRCM). She is also an Assistant Clinical Professor in the Department of
Medicine at Université de Montréal, an infectious diseases specialist at Centre Hospitalier de
‘Université de Montréal (CHUM), and holds a Canada Research Chair in the Role of the
Microbiome in Primary Immunodeficiency. Read more…

Speaker 06

Prof. Sylvain Moineau

Canada Research Chair in Bacteriophages, Université Laval, Canada

Dr. Sylvain Moineau, Canada Research Chair in Bacteriophages, aims to improve knowledge of the biology of phages. He is using an integrated approach that combines genomic and proteomic data, as well as data from other fields, to better understand interactions between phages and bacteria.
He aims to develop new tools that would eliminate bacteriophages in dairy fermentation and that could be used as antibacterials in public health and in a wide variety of industries.
Moineau’s research will go far towards increasing the friendly use of bacteriophages and to reducing their more harmful traits.